Missing/wrong data?
Log in to edit
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma
scientific article
Author/s
author: Alexander M. M. Eggermont, Caroline Robert, Adil Daud, Dirk Schadendorf, Ulrich Keilholz, Axel Hauschild, Jens Gille
Work details
Publication date
April 6, 2009
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.